Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality headsets could calm women before cancer surgery

NCT ID NCT07016880

Symptom relief Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a 20-minute virtual reality relaxation session can reduce anxiety and improve vital signs in women scheduled for gynecologic cancer surgery. Sixty-six participants will be randomly assigned to either the VR session or standard care. Researchers will measure anxiety levels, blood pressure, heart rate, and patient satisfaction before and after the intervention.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality relaxation session
What this could lead to
If it works, this could offer a simple, drug-free way to help women feel calmer before gynecologic cancer surgery.
What could go wrong
This is a small, early-stage trial with only 66 participants, so results may not apply to everyone. The effect may be small or no better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 66 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The participant must have a confirmed diagnosis of gynecological cancer. * The participant must be aware of their gynecological cancer diagnosis. * Participants must be 18 years of age or older. * Verbal and written informed consent to participate in the study must be obtained. * The participant must be able to communicate verbally and in writing in Turkish. * No communication impairments (e.g., visual, auditory, or cognitive) should be present. * This must be the participant's first surgical intervention related to gynecological oncology. * Eastern Cooperative Oncology Group (ECOG) Performance Status must not exceed 2. * The planned surgical procedure must be a laparotomy. Exclusion Criteria: * History of recurrent gynecological cancer. * Presence of vision problems that prevent the use of VR goggles, including participants who wear glasses or have uncorrected vision impairment. * Presence of conditions such as migraines, vertigo, active nausea, vomiting, or frequent headaches. * Sensitivity to motion sickness. * Diagnosis of a psychiatric condition, whether under pharmacological or non-pharmacological treatment. * Withdrawal of consent during the study. * Removal of the virtual reality headset during the intervention. * Development of any medical complications during the intervention period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gynecological cancers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gynecological cancers Gynecological surgery Preoperative anxiety Women'S health

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hacettepe University

    RECRUITING

    Ankara, 06100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.